AdvanSix (NYSE:ASIX) reported Q1 EPS of $2.15, $0.44 better than the analyst estimate of $1.71. Revenue for the quarter came in at $479.1 million versus the consensus estimate of $481.77 million.
Outlook:
Targeting significant earnings growth in 2022 supported by advantages of integrated business model and expected robust ammonium sulfate fertilizer performance
Expect continued healthy North America demand for nylon and chemical intermediates
Successful integration of U.S. Amines expected to deliver year one earnings accretion
Continue to expect Capital Expenditures to be $95 to $105 million in 2022
Expect pre-tax income impact of planned plant turnarounds to be approximately $32 to $37 million in 2022